Table 2 Study population and patient demographics (n = 30)
Patient characteristic | N (%) |
|---|---|
Male | 17 (56.7) |
Age ≥ 65 years | 22 (73.3) |
HA-CDI | 26 (86.7) |
CA-CDI | 4 (13.3) |
Recurrent CDI | 4 (13.3) |
Severe CDI—Horn’s index | 17 (56.7) |
Severe CDI—Atlas score | 18 (60) |
Mortality within 3 months | 8 (26.7) |
CDI cause of death | 2 (6.7) |
Previous hospitalisation | 13 (59.1) |
Previous antibiotic use | 25 (83.3) |
Aminopenicillin/beta-lactamase inhibitors | 12 (40) |
Cephalosporines | 11 (36.7) |
Fluoroquinolones | 12 (40) |
Carbapenems | 4 (13.3) |
Piperacilin/tazobactam | 3 (10) |
Aminoglycosides | 3 (10) |